Skip to main content
logo
Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
28.46
+0.50 (1.79%)
At close: Aug 31, 2026, 4:00 PM EDT
28.51
+0.05 (0.18%)
After-hours: Aug 31, 2026, 7:59 PM EDT

Pfizer Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Oct '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21 Oct '21
Operating Revenue
15,03414,45017,55716,65414,65313,71517,76417,70113,28314,87814,57013,49213,00618,48524,29022,63827,74225,66123,83824,035
Other Revenue
-1-----11---1-1-------
Revenue
15,03414,45117,55716,65414,65313,71517,76317,70213,28314,87814,56913,49213,00718,48524,29022,63827,74225,66123,83824,035
Revenue Growth (YoY)
2.60%5.37%-1.16%-5.92%10.31%-7.82%21.92%31.20%2.12%-19.51%-40.02%-40.40%-53.11%-27.96%1.90%-5.81%46.79%76.78%108.61%133.87%
Cost of Revenue
3,6553,4075,0653,9793,5012,5926,5134,8732,7683,0361,0668,9053,0724,7479,4756,0378,6259,9589,7119,900
Gross Profit
11,37911,04412,49212,67511,15211,12311,25012,82910,51511,84213,5034,5879,93513,73814,81516,60119,11715,70314,12714,135
Selling, General & Admin
3,2572,8403,7353,0853,2942,9104,7443,1143,5593,3484,1283,1123,3343,2763,8532,9353,1942,2182,9781,659
Research & Development
2,7462,4523,3232,4922,4432,1793,1012,5652,6762,4802,7732,6822,6292,4943,6152,6962,8152,3013,4472,681
Amortization of Goodwill & Intangibles
1,1851,1831,2301,2231,2111,2111,3591,3121,3071,3081,2671,1791,1841,1031,131822822835957968
Operating Expenses
7,1886,4758,2886,8006,9486,3009,2046,9917,5427,1368,1686,9737,1476,8738,5996,4536,8315,3547,3825,308
Operating Income
4,1914,5694,2045,8754,2044,8232,0465,8382,9734,7065,335-2,3862,7886,8656,21610,14812,28610,3496,7458,827
Interest Expense
-667-668-711-652-654-654-739-783-778-790-688-695-508-318-313-311-293-322-316-325
Interest & Investment Income
21119724713822918226011613019087252331648045170301418110
Earnings From Equity Investments
-------15040-8815113115668153-51149184164105
Currency Exchange Gain (Loss)
----------164----321-420---95-74
Other Non Operating Income (Expenses)
515361,353181172103-56-21716750-3662291881505741,079206294612529
EBT Excluding Unusual Items
4,2504,1345,0935,5423,9514,4541,5115,1042,5324,0685,468-2,1982,9407,2456,76010,51512,37810,5197,2919,072
Merger & Restructuring Charges
-1,242-619-847-564-332-887-935-774-1,838-494-2,873-413-621-187-1,242-367-355-303-427-802
Gain (Loss) on Sale of Investments
1,833-9-4020175-3702,562446-3421752,299-393135-45180-112-541-699-257400
Gain (Loss) on Sale of Assets
-------420---222---6-7-1-1
Asset Writedown
-4,325--4,363-260-93-224-2,946--240-109-2,888---264-221-200---86-
Legal Settlements
-842-191-302-191-422-142-145-45-169-208-228-71-139-36-55-77-19-79-70-38
Other Unusual Items
-311-9-971-4-133-38451-3-40-11-6,185-210-13-16-25-228-14-33-156-28
Pretax Income
-6533,169-1,6423,3343,0442,784-104,715-1033,421-4,129-3,3522,2696,2705,2309,00011,4489,0513,8267,843
Income Tax Expense
-407461-2-216141-189-421234-134293-795-964-717152303561,5701,172249-328
Earnings From Continuing Operations
-2462,708-1,6403,5502,9032,9734114,481313,128-3,334-2,3882,3405,5555,0008,6449,8787,8793,5778,171
Earnings From Discontinued Operations
8-13--25-7-817-5-2612-212-2134-9-186-13
Net Income to Company
-2382,695-1,6403,5502,9282,9734184,473483,123-3,360-2,3762,3385,5565,0028,6239,9127,8703,3918,158
Minority Interest in Earnings
-10-8-8-9-18-6-8-8-7-8-9-6-11-13-8-15-6-62-12
Net Income
-2482,687-1,6483,5412,9102,9674104,465413,115-3,369-2,3822,3275,5434,9948,6089,9067,8643,3938,146
Net Income to Common
-2482,687-1,6483,5412,9102,9674104,465413,115-3,369-2,3822,3275,5434,9948,6089,9067,8643,3938,146
Net Income Growth (YoY)
--9.44%--20.69%6997.56%-4.75%---98.24%-43.80%---76.51%-29.51%47.19%5.67%78.07%61.25%301.06%454.53%
Shares Outstanding (Basic)
5,6995,6915,6865,6855,6855,6755,6675,6675,6665,6575,6475,6465,6465,6345,6155,6075,5935,6175,6165,609
Shares Outstanding (Diluted)
5,6995,7315,6865,7145,7065,7105,7035,7055,6965,6975,6475,6465,7135,7275,7435,7185,7125,7585,7685,725
Shares Change (YoY)
-0.12%0.37%-0.30%0.16%0.18%0.23%0.99%1.04%-0.30%-0.52%-1.67%-1.26%0.02%-0.54%-0.43%-0.12%0.60%1.70%1.87%1.63%
EPS (Basic)
-0.040.47-0.290.620.510.520.070.790.010.55-0.60-0.420.410.980.891.541.771.400.601.45
EPS (Diluted)
-0.040.47-0.290.620.510.520.070.790.010.55-0.60-0.420.410.970.871.511.741.370.591.43
EPS Growth (YoY)
--10.05%--21.31%6973.98%-5.30%---98.23%-43.40%---76.40%-29.10%47.11%5.50%77.42%59.09%289.72%450.37%

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Oct '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21 Oct '21
Free Cash Flow
3022,1794,5034,001-1,7715,8046,063-2,4183864,1962,646-2,122737,5815,1337,4195,8984,91210,211
Free Cash Flow Per Share
0.050.380.790.70-0.311.021.06-0.420.070.740.47-0.370.011.320.901.301.020.851.78
Dividend Per Share
0.4300.4300.8600.4300.4300.4300.8400.4200.4200.4200.4100.4100.4100.4100.4000.4000.4000.4000.3900.390
Dividend Growth (YoY)
0%0%2.38%2.38%2.38%2.38%104.88%2.44%2.44%2.44%2.50%2.50%2.50%2.50%2.56%2.56%2.56%2.56%2.63%2.63%
Gross Margin
75.69%76.42%71.15%76.11%76.11%81.10%63.33%72.47%79.16%79.59%92.68%34.00%76.38%74.32%60.99%73.33%68.91%61.19%59.26%58.81%
Operating Margin
27.88%31.62%23.95%35.28%28.69%35.17%11.52%32.98%22.38%31.63%36.62%-17.69%21.44%37.14%25.59%44.83%44.29%40.33%28.29%36.73%
Profit Margin
-1.65%18.59%-9.39%21.26%19.86%21.63%2.31%25.22%0.31%20.94%-23.12%-17.66%17.89%29.99%20.56%38.02%35.71%30.65%14.23%33.89%
Free Cash Flow Margin
2.01%15.08%25.65%24.02%-12.91%32.67%34.25%-18.20%2.59%28.80%19.61%-16.31%0.40%31.21%22.67%26.74%22.98%20.61%42.48%
EBITDA
5,8026,1795,8647,5335,8266,4373,8347,5854,7006,4387,001-8314,3568,3347,72111,32413,45511,5278,06910,141
EBITDA Margin
38.59%42.76%33.40%45.23%39.76%46.93%21.58%42.85%35.38%43.27%48.05%-6.16%33.49%45.08%31.79%50.02%48.50%44.92%33.85%42.19%
D&A For EBITDA
1,6111,6101,6601,6581,6221,6141,7881,7471,7271,7321,6661,5551,5681,4691,5051,1761,1691,1781,3241,314
EBIT
4,1914,5694,2045,8754,2044,8232,0465,8382,9734,7065,335-2,3862,7886,8656,21610,14812,28610,3496,7458,827
EBIT Margin
27.88%31.62%23.95%35.28%28.69%35.17%11.52%32.98%22.38%31.63%36.62%-17.68%21.44%37.14%25.59%44.83%44.29%40.33%28.29%36.73%
Effective Tax Rate
-14.55%--4.63%--4.96%-8.57%---11.40%4.40%3.96%13.71%12.95%6.51%-
Revenue as Reported
15,03414,45117,55716,65414,65313,71517,76317,70213,28314,87914,56913,49113,00718,486100,330-----
SEC Filings: 10-K · 10-Q